Call us +91 -7376325889/ 7376335889
Mail
Support
Partners
Careers
Knowledge Center
Downloads
Margin Calculator
Equity
F&O
MF
Online Trading
Open an Account
Back Office
Apply IPO
ABOUT US
SERVICES
MARKETS
Equity
Derivatives
Mutual Fund
IPO
PORTFOLIO
OUR RECOMMENDATIONS
CONTACT US
CALCULATORS
MENU
×
HOME
SERVICES
MARKETS
PORTFOLIO
OUR RECOMMENDATIONS
ABOUT US
SERVICES
CONTACT US
CALCULATORS
Online Trading
Open an Account
Back Office
Apply IPO
Equity Analysis
Company Profile
Price
Volume
Analysis
Company Profile
News Analysis
Corporate Action
Other Markets
Detailed Quotes
Detailed Quotes
Company Snapshot
Company Background
Board of Directors
Profit & Loss
Balance Sheet
Quarterly Results
Key Financial Ratios
Share Holding Pattern
Directors Report
Score Board
MF Holdings
Name Change
Company News
Peer Comparison
Monthly High / Low
Price Chart
Consolidated Quarters
FII Holding
Simple & CAGR Growth
Deliverable Volumes
Company News
Infinium Pharmachem Ltd
Industry : Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value(
)
78690
INE0MRE01011
41.5009744
NSE Symbol
P/E(TTM)
Mar.Cap(
Cr.)
INFINIUM
37.63
417.34
EPS(TTM)
Face Value(
)
Div & Yield %:
7.97
10
0
Back
HDFC Bank Ltd
RBI approves HDFC Bank's acquisition of up to 9.50% stake in AU Small Finance Bank
Jan 04,2025
AU Small Finance Bank (AU SFB) has received a copy of letter of the Reserve Bank of India (RBI) dated January 3, 2025 addressed to HDFC Bank that it has accorded its approval to the HDFC Bank (which includes its group entities viz HDFC Mutual Fund, HDFC Life Insurance Co., HDFC Pension Management Co., HDFC ERGO General Insurance Co. and HDFC Securities) to acquire ‘aggregate holding' of up to 9.50% of the paidup share capital or voting rights in the AU SFB within one year from the date of RBI approval letter, failing which RBI approval shall stand cancelled.